Google Übersetzer
Os Therapies Incorporated
About
Os Therapies Incorporated — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 13 2026
OS Therapies Appoints Biotech Industry Luminary Robert "Bob" S. Langer, PhD as Strategic Advisor
Apr 8 2026
OS Therapies Appoints Craig Eagle, MD as Strategic Advisor
Apr 2 2026
OS Therapies Completes $5.25M Registered Direct Offering Primarily with Pre-Existing High-Net-Worth Investors
Mar 31 2026
OS Therapies Completes Submission of Biomarker & Clinical Data for U.S. FDA Pre-BLA Meeting, Reports Full Year 2025 Financial Results and Provides Business Update
Mar 27 2026
OS Therapies Granted Meetings with U.S. FDA, U.K. MHRA, EMA and Australian Therapeutic Goods Administration to Review Global Confirmatory Phase 3 Trial for OST-HER2 in Metastatic Osteosarcoma